The largest database of trusted experimental protocols

33 protocols using oleic acid

1

Preparation of Fatty Acid-BSA Solutions

Check if the same lab product or an alternative is used in the 5 most similar protocols
The palmitic acid stock solution was prepared using fatty acid-free BSA (A8806, Sigma) at a molar ratio of 3.3:1 (palmitic:BSA) [45 (link)]. To prepare the stock solution, 500 mM palmitic acid (P0500, Merck) was dissolved in absolute ethanol at 70 °C. Then, 10 μL of palmitic acid solution was added to 1 mL prewarmed 10% BSA (prepared in cell culture medium). The mixture was incubated at 55 °C until it became clear and was then filtered before use. For the vehicle control, 10 μL ethanol was mixed with 1 mL 10% BSA. Oleic acid was prepared at a molar ratio of 6:1 (Oleic acid:BSA) using the product (29557, Cayman, MI, USA). The vehicle stock solution was prepared by dissolving 0.8 mM BSA in 150 mM sodium chloride (S3014, Sigma).
+ Open protocol
+ Expand
2

Polarization of Bone Marrow-Derived Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMMФ were stimulated either with IL-4 (10 ng/ml, AF-214-14, Peprotech), lipopolysaccharide (100 ng/ml, Sigma) or dexamethasone (100nM, D4902, Sigma) to respectively achieve M(IL-4), M(LPS) or M(GC) polarization state. In some experiments, BMMФ were treated with C75 (Sigma), Cerulenin (Sigma), Etomoxir (Sigma), pan-AKT inhibitor MK-2206 (1 mM, Cayman Chemical), 25-hydroxycholesterol (10 μM, Cayman chemical), N-acetyl cysteine (10mM, Sigma), Diphenyleneiodonium chloride (DPI, 5 μM, Sigma), L-NG-Nitroarginine methyl ester (L-NAME, 1mM, Cayman Chemical), Allopurinol (100 μM, Sigma), hydrogen peroxide (Sigma), SIRT1 activator II (Sigma), EX-527 (Sigma), Compound C (Sigma), AICAR (Abcam), HMGCoA (Sigma), water-soluble cholesterol (Cholesterol–methyl-β-cyclodextrin, Sigma) or Simvastatin (Sigma).
For fatty acid treatment, palmitic or oleic acid (Cayman) were solubilized at 100mM in absolute ethanol at 60°C. Fatty acid were conjugated at the desired concentration using a sonicator water bath into the macrophage culture medium to avoid endotoxin contamination from BSA54 (link).
+ Open protocol
+ Expand
3

Deuterated Fatty Acid Metabolism in Vascular Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human aorta endothelial cells line (HAEC) was obtained from Lonza (Basel, Switzerland). Vascular smooth muscle cell line (MOVAS) was purchased from American Type Culture Collection (ATCC, Rockville, Maryland, MD, USA). HAECs were maintained in supplemented endothelial growth medium EGM-2 (Lonza, Basel, Switzerland), MOVAS cells were cultured in DMEM supplemented 10% (v/v) FBS (both from Gibco, Scotland, UK). Cultured were maintained at 37 °C in a humidified atmosphere of 5% CO2—95% air. When cells achieved 90% confluence the medium was changed and cells were treated with 100 μM deuterated Oleic acid (OAd34, Sigma Aldrich) or deuterated arachidonic acid (AAd8, 25 µM, Cayman Chemical) in the presence or absence of lipolysis inhibitor, atglistatin (50 µM), phospholipase A2 inhibitor (AACOCF3, 10 µM, Abcam), COX-1 inhibitor (SC-560, Cayman Chemical) or COX-2 inhibitor (Dup-697, Cayman Chemical) for 4 h or 24 h. Oleic acid (Cayman Chemical) for the experiments was freshly saponified using 100 mM NaOH and BSA-conjugated (10% in DPBS, low endotoxin, fatty acid-free, suitable for cell culture, sterile-filtered; Sigma Aldrich). After 4 h or 24 h of incubation cells were fixed for 4 min with 4% paraformaldehyde. Fixed cells were washed 3 times with DPBS and stored in DPBS at 4 °C until the execution of the measurements.
+ Open protocol
+ Expand
4

Fatty Acids Modulation of Neuronal Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
All chemical compounds were purchased from Wako unless otherwise stated. DHA (cis-4,7,10,13,16,19-docosahexaenoic acid: DHA), DHA-Me, ARA, EPA (cis-5,8,11,14,17-eicosapentaenoic acid), DHK, indomethacin, and Triton X-100 were purchased from Sigma. DHA-CoA and CoA were purchased from Avanti. Oleic acid, linOleic acid, ALA, cis-11,14-eicosadienoic acid, cis-11,14,17-eicosatrienoic acid, cis-13,16,19-docosatrienoic acid (DTriA), cis-7,10,13,16-docosatetraenoic acid (DTetA), cis-7,10,13,16,19-docosapentaenoic acid (DPA), and N-(2-hydroxyethyl)-4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenamide (DHA-EA) were purchased from Cayman Chemical. L-Glu stock solution (20 mM) in purified water (DIRECT-Q; Millipore) was diluted to the required final concentration with ND96 just before application. Stock solutions of fatty acids (100 mM) in ethanol was diluted to the required final concentration with ND96 on demand and used within 2 h to avoid precipitation. We confirmed that the vehicle had no effect prior to each experiment.
+ Open protocol
+ Expand
5

Lipid Metabolism in HepG2 Hepatocellular Carcinoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human liver hepatocellular carcinoma cell line (HepG2 cells) was
purchased from the American Type Culture Collection (ATCC; Manassas, VA). Cells
were cultured in EMEM (ATCC) supplemented with 10% fetal bovine serum
(Life Technologies; Carlsbad, CA) in 25 cm2 polystyrene flasks placed
in a Hera Cell 5% CO2 37°C incubator (ThermoFisher
Scientific; Waltham, MA). Routine passage was carried out every 2 or 3 days.
About 2 × 105 HepG2 cells were seeded per 6-cm plate
and serum-starved for 24 h before the following treatments: 50, 100 or 200
μg/ml human LDL-cholesterol (LDL-C) (Kalen Biomedical; Montgomery Vlg,
MD); 10, 30 or 90 μM simvastatin (Sigma; St Louis, MO); 100 nM insulin
(Sigma); 30 nM glucose (Sigma); 5 μM Bay-11 (Cayman; Ann Arbor, MI); 200
μM fatty acids conjugated with 0.2% BSA (30 mM) in 1%
ethanol. We treated HepG2 cells for 24 h with palmitic acid (Sigma), palmitoleic
acid, stearic acid, oleic acid, linoleic acid, linolenic acid, and
eicosapentaenoic acid (Cayman).
+ Open protocol
+ Expand
6

Fatty Acid Extraction and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Phytomonic acid (C18 CFA), palmitoleic acid (C16∶1), palmitic acid (C16∶0), oleic acid (C18∶1n9), and stearic acid (C18∶0) were obtained from Cayman Chemical (MI). Lauric acid (C12∶0), myristic acid (C14∶0), vaccenic acid (C18∶1n7), elaidic acid (trans-C18∶1n9), linoleic acid (C18∶2n6), arachidonic acid (C20∶4n6), and eicosapentaenoic acid (C20∶5n3) were from Nu-Chek Prep, Inc. (MN). All solvents were of GC-MS grade and all other reagents were of the highest grade available.
+ Open protocol
+ Expand
7

Fatty Acid Modulation of Dendritic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fatty acids (FAs) were purchased from Cayman and diluted in ethanol for all FAs [Palmitic acid (PA, C16:0), stearic acid(C18:0), palmitoleic acid (C16:1), oleic acid (OA, C18:1n-9), linoleic acid (LA, C18:2n6c), cis-8,11,14-eicosatrienoic acid (C20:3n6), cis-11,14,17- eicosatrienoic acid (C20:3n3), erucic acid (C22:1n9), eicosapentaenoic acid (EPA, C20:5n3), nervonic acid (C24:1n9), docosahexenoic acid (DHA, C22:6n3) and arachidonic acid (AA, C20:4n-6)] . The FAs-free medium was contained RPMI-1640 basic medium, 1×ITS medium supplement (Sigma) and 20 ng/ml GM-CSF without FAs supplement. Before addition to the culture medium, all FAs were conjugated to bovine serum albumin (BSA, fatty acid-free, Sigma) at the indicated concentration with FAs-free medium containing 1% BSA. The fatty acids were incubated with 1% BSA for 2 h before adding to DC. The concentration of saturated, monounsaturated, and polyunsaturated fatty acids in ITS medium was 20 µM. Half of the medium was discarded and replaced with fresh DC medium every other day. On day 6, DC were infected with the virus for 24 h and then analyzed by FACS.
+ Open protocol
+ Expand
8

Multiparametric Flow Cytometry Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
We followed the procedures described in [33 (link)]. Positive controls cells for LD and apoptosis were treated with 75 µM oleic acid (Cayman Chemical, Ann Arbor, MI, USA) or Staurosporine 10 µM for 24 h, respectively. Cells were then harvested and centrifuged at 300 g, for 10 min at RT. Subsequently, cells were re-suspended in PBS (Sigma-Aldrich) and 5 mM 2′,7′-Dichlorodihydrofluorescein diacetate (CM-H2DCFA) (Thermo Fisher Scientific, St. Louis, MO, USA) (for ROS) or 0.5 µg/mL boron dipyrromethene (BODIPY) 483/503 (for LD) and incubated for 30 min at 37 °C (for ROS) or RT (for LD). Then, 1 drop/0.5 mL of Annexin V-Pacific Blue (Annexin V-Pacific Blue Ready Flow Reagent, Thermo Fisher Scientific, St. Louis, MI, USA) was added to the mixture. After 15 min, the cell fluorescence was measured using the flow cytometer FACS Melody (Becton Dickinson Biosciences, Franklin Lakes, NJ, USA) equipped with violet (405 nm), blue (488 nm) and yellow/green (561 nm) lasers. Cells for ROS positive control were also incubated with 5 mM H2O2 for 30 min after staining and before measurement. For cytotoxicity, we used the Annexin V-Pacific Blue Ready Flow Reagent (Thermo Fisher Scientific, St. Louis, MO, USA) staining kit to monitor apoptosis using flow cytometry. Samples were stained for cytotoxicity when prepared for ROS and LD detection.
+ Open protocol
+ Expand
9

Fatty Acid Conjugation and Cell Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oleic acid (OA, C18:1), arachidonic acid (AA, C20:4), docosapentaenoic acid (DPA, C22:5), and docosahexaenoic acid (DHA, C22:6) were purchased from Cayman Chemicals and conjugated with fatty-acid free BSA (Sigma-Aldrich) using previously described protocols(Hannah et al., 2001 (link)). Briefly, a 0.1M stock solution of each fatty acid was prepared by diluting the free fatty acid in ethanol and neutralizing it with the excessive NaOH at 0.25 M final concentration. The precipitated sodium salt was then evaporated under nitrogen gas, reconstituted with 10% defatted BSA in 0.15 M NaCl. Each solution was adjusted to pH 7.4 with NaOH and stored in multiple aliquots at −20 °C protected from light and oxygen. The cells were treated with 20 μM indicated free fatty acid for 3 days prior to viability assays or imaging analysis.
+ Open protocol
+ Expand
10

Optimized neuronal culture media

Check if the same lab product or an alternative is used in the 5 most similar protocols
BrainPhys neuronal media (Stem Cell Technologies) supplemented with 1X B27 with vitamin A (ThermoFisher), 1X N2 Plus media supplement (R&D Systems), 20 ng/ml BDNF (Peprotech), 20 ng/ml GDNF (Peprotech), 1 mM creatine (Sigma-Aldrich), 200 nM L-ascorbic acid (Sigma-Aldrich), 1 μg/ml mouse laminin (ThermoFisher), 0.5 mM glutamax (ThermoFisher), 0.5X penicillin-streptomycin (ThermoFisher), 1X Normocin (Invivogen), 5 ng/ml TGF-b (Peprotech), 100 ng/ml human IL-34 (Peprotech), 1.5 μg/ml cholesterol (Sigma-Aldrich), 1 ng/ml gondoic acid (Cayman Chemicals), 100 ng/ml oleic acid (Cayman Chemicals), 460 μM Thioglycerol (Sigma-Aldrich), 1X Insulin-Transferrin-Selenium (ThermoFisher), 25 ng/ml rhM-CSF (Peprotech), and 5.4 μg/ml Human Insulin Solution (Sigma).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!